Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial

Streptococcus pneumoniae is an important pathogen causing invasive diseases such as sepsis, meningitis, and pneumonia. Vaccines have become the most effective way to prevent pneumococcal infections. This phase III trial was designed to evaluate the immunogenicity and safety of a 23-valent pneumococc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Kong, Yujia, Zhang, Wei, Jiang, Zhiwei, Wang, Ling, Li, Chanjuan, Li, Yanping, Xia, Jielai
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635697/
https://ncbi.nlm.nih.gov/pubmed/26083953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1055429
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller